We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.6B
AUM Growth
+$1.71B
Cap. Flow
-$406M
Cap. Flow %
-1.72%
Top 10 Hldgs %
52.37%
Holding
196
New
43
Increased
37
Reduced
38
Closed
21

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$502M
2
UNH icon
UnitedHealth
UNH
+$254M
3
ABNB icon
Airbnb
ABNB
+$243M
4
AON icon
Aon
AON
+$196M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$152M

Top Sells

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$311M
2
TMO icon
Thermo Fisher Scientific
TMO
+$228M
3
BX icon
Blackstone
BX
+$222M
4
TRU icon
TransUnion
TRU
+$203M
5
SPLK
Splunk Inc
SPLK
+$202M

Sector Composition

Rank Sector Weight
1 Healthcare 26.88%
2 Technology 10.2%
3 Financials 8.76%
4 Energy 8.1%
5 Industrials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
101
DELISTED
Centessa Pharmaceuticals
CNTA
$4.19M 0.02%
+371,000
New +$3.51M
AMLX icon
102
Amylyx Pharmaceuticals
AMLX
$2.54B
$3.27M 0.01%
+1,150,221
New +$15M
IVCP
103
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$3.25M 0.01%
300,000
– –
COGT icon
104
Cogent Biosciences
COGT
$7.24B
$3.1M 0.01%
462,000
+445,000
+2,618% +$2.75M
PRAX icon
105
Praxis Precision Medicines
PRAX
$10.1B
$3.05M 0.01%
+50,000
New +$2.24M
BACA
106
DELISTED
Berenson Acquisition Corp. I
BACA
$2.96M 0.01%
285,715
– –
AVBP icon
107
ArriVent BioPharma
AVBP
$1.44B
$2.71M 0.01%
+151,768
New +$3.06M
ARYD
108
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.25M 0.01%
200,000
– –
MTAL
109
DELISTED
Metals Acquisition
MTAL
$2.02M 0.01%
157,500
– –
MTAL.WS
110
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$1.75M 0.01%
825,000
– –
SMC
111
Summit Midstream
SMC
$419M
$1.63M 0.01%
58,214
– –
GATE
112
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.57M 0.01%
150,000
– –
TVRD
113
Tvardi Therapeutics
TVRD
$23.4M
$1.42M 0.01%
43,229
– –
FBRX icon
114
Forte Biosciences
FBRX
$1.57B
$1.27M 0.01%
72,418
– –
GRND.WS
115
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$1.25M 0.01%
540,000
– –
SLNO
116
DELISTED
Soleno Therapeutics
SLNO
$1.19M 0.01%
27,750
-137,469
-83% -$6.22M
VNET
117
VNET Group
VNET
$2.09B
$1.01M ﹤0.01%
650,000
-1,125,000
-63% -$2.08M
MDGL icon
118
Madrigal Pharmaceuticals
MDGL
$11.8B
$886K ﹤0.01%
3,319
– –
SAGE
119
DELISTED
Sage Therapeutics
SAGE
$802K ﹤0.01%
42,800
– –
LUNRW
120
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$772K ﹤0.01%
440,965
-509,035
-54% -$480K
LU icon
121
Lufax Holding
LU
$1.3B
$633K ﹤0.01%
149,999
– –
IOVA icon
122
Iovance Biotherapeutics
IOVA
$2.87B
$385K ﹤0.01%
26,000
-536,000
-95% -$6.24M
BPMC
123
DELISTED
Blueprint Medicines
BPMC
$379K ﹤0.01%
4,000
– –
KRYS icon
124
Krystal Biotech
KRYS
$9.66B
$356K ﹤0.01%
2,000
– –
APLS
125
DELISTED
Apellis Pharmaceuticals
APLS
$353K ﹤0.01%
6,000
– –
3 4
5
6 7

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Farallon Capital Management held 196 positions worth $23.6B, up 7.8% from $21.9B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Farallon Capital Management's Q1 2024 filing shows 43 new, 37 increased, 38 reduced and 21 closed positions. Its largest new stake was Airbnb: 1,608,220 shares worth $265M. The largest sale was Charter Communications, an estimated $311M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q1 2024 buy was Airbnb: 1,608,220 shares worth $265M.
  • Farallon Capital Management added most to Hess in Q1 2024, an estimated $502M increase.
  • Farallon Capital Management's biggest Q1 2024 reduction was Thermo Fisher Scientific, cutting an estimated $228M.
  • Farallon Capital Management fully exited Charter Communications in Q1 2024, selling an estimated $311M.
  • Farallon Capital Management's ten largest holdings make up 52% of its $23.6B portfolio in Q1 2024.
  • Farallon Capital Management opened 43 new positions and closed 21 in Q1 2024.
  • Farallon Capital Management's portfolio value rose 7.8% quarter-over-quarter to $23.6B.

Based on Farallon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.